Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data-Reference-Cited by-同舟云学术

Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data

Published:2011-10-27 Issue:2 Volume:51 Page:127-139
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Wang Lu,Motoi Toru,Khanin Raya,Olshen Adam,Mertens Fredrik,Bridge Julia,Cin Paola Dal,Antonescu Cristina R.,Singer Samuel,Hameed Meera,Bovee Judith V.M.G.,Hogendoorn Pancras C. W.,Socci Nicholas,Ladanyi Marc

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.20937/fullpdf

Reference24 articles.

1. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours;Amary;J Pathol,2011

2. Mesenchymal chondrosarcoma of the maxilla with diffuse metastasis: Case report and literature review;Aziz;J Oral Maxillofac Surg,2002

3. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia;Carapeti;Blood,1998

4. Mesenchymal chondrosarcoma of the maxilla;Chidambaram;J Laryngol Otol,2000

5. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP;Deguchi;Cancer Cell,2003

Cited by 277 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: A mesenchymal chondrosarcoma with alternative HEY1::NCOA2 fusions in the sella turcica;Pathology and Oncology Research;2024-08-06

2. VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300;2024-07-01

3. VGLL2 and TEAD1 fusion proteins drive YAP/TAZ-independent transcription and tumorigenesis by engaging p300;2024-07-01

4. Uterine Tumor Resembling Ovarian Sex-Cord Tumor (UTROSCT): A Rare Polyphenotypic Neoplasm;Diagnostics;2024-06-17

5. How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting;Journal of Molecular Pathology;2024-06-04